Literature DB >> 34423239

Thrombosed sinus of Valsalva aneurysm masquer ading as a cardiac tumour: a case report.

Wakana Sato1, Katsuhito Seki1, Hiroshi Yamamoto2, Hiroyuki Watanabe1.   

Abstract

BACKGROUND: An aortic sinus of Valsalva aneurysm (SVA) often remains undiagnosed until it ruptures. An SVA filled with thrombus can be challenging to diagnose accurately. CASE
SUMMARY: A 70-year-old man was admitted with a clinical diagnosis of well-tolerated complete atrioventricular block (AVB). Transthoracic echocardiography revealed a spherical mass (43 × 49 mm) at the interatrial septum. Enhanced computed tomography (CT) showed a well-defined, hollow, and non-enhanced mass suggesting a cardiac tumour. However, 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) showed no uptake in the mass. After implantation of a permanent pacemaker, anticoagulant therapy was started for paroxysmal atrial fibrillation. Two months later, follow-up evaluation by echocardiography and enhanced CT revealed an increase in size of the hollow interior cavity, suggesting thrombolysis by the anticoagulant. We diagnosed a non-coronary SVA filled with thrombus, which masqueraded as a cardiac tumour and may have caused complete AVB.
CONCLUSIONS: We describe a rare case of a giant thrombosed SVA masquerading as a cardiac tumour. Initial 18F-FDG PET/CT and serial imaging studies were helpful in distinguishing it from a cardiac tumour.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Cardiac tumour; Case report; Complete AV block; Sinus of Valsalva aneurysm; Thrombus

Year:  2021        PMID: 34423239      PMCID: PMC8374963          DOI: 10.1093/ehjcr/ytab259

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Introduction

An aortic sinus of Valsalva aneurysm (SVA) often remains undiagnosed until it ruptures, usually into the right ventricle or atrium. The rupture may be clinically silent, or may present with symptoms of dyspnoea and chest pain, or with a new continuous to-and-fro murmur. An SVA filled with thrombus can be challenging to diagnose accurately. We describe a 70-year-old man who presented with new-onset complete atrioventricular block (AVB) as the first manifestation of a thrombosed SVA masquerading as a cardiac tumour. An sinus of Valsalva aneurysm (SVA) filled with thrombus can occasionally masquerade as a cardiac tumour. In addition to 18F-fluorodeoxyglucose positron emission tomography/computed tomography (CT), changes of internal structure on echocardiography and enhanced CT can be helpful in distinguishing it from a cardiac tumour. Although rupture and aortic regurgitation are common complications of an SVA, it may cause atrioventricular block.

Timeline

Case presentation

A 70-year-old man with complete AVB was referred to our hospital for further evaluation and treatment (Figure ). His initial chief complaint was faintness. Observation with careful haemodynamic monitoring revealed well-tolerated complete AVB. No heart murmur was heard. His vital signs were as follows: heart rate 42 beats/min, blood pressure 126/69 mmHg, SpO2 99%, and temperature 36.5°C. He had a medical history of hypertension and a single kidney and had been taking an angiotensin II receptor blocker, calcium channel blocker, and β blocker. Even after discontinuation of the calcium channel blocker and β blocker, electrocardiogram monitoring showed complete AVB and frequent paroxysmal atrial fibrillation with junctional escape rhythm. A chest X-ray showed cardiomegaly with a cardiothoracic ratio of 55%. Surprisingly, transthoracic echocardiography (TTE) revealed a spherical mass (43 × 49 mm) in the centre of the heart with normal left ventricular systolic function (Figure , Video 1). Blood tests showed an elevated brain natriuretic peptide level of 84.3 pg/mL (normal value: 0–18.4 pg/mL), serum creatinine of 1.12 mg/dL (normal value: 0.46–0.79 mg/dL), and D-dimer of 1.87 μg/mL (normal value: 0–0.99 μg/mL) but were otherwise normal. The tumour marker levels, such as soluble interleukin-2 receptor, squamous cell carcinoma, pro-gastrin-releasing peptide, neuron-specific enolase, and cytokeratin 19 fragment, were within the normal range. Contrast-enhanced computed tomography (CT) showed a well-defined, hollow, 4.5 cm, non-enhanced mass in the interatrial septum (Figure ). Transoesophageal echocardiography confirmed that the mass was close to the atrial septum without invasion (Figure , Video 2). Cardiac magnetic resonance imaging showed excellent delineation of the tumour, the internal contents of which showed high signal intensity on a T2-weighted image and iso-signal intensity on a T1-weighted image. Based on these findings, we suspected that this was a cardiac tumour arising from the interatrial septum or the wall of the non-coronary sinus of Valsalva. However, 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) revealed no uptake in the mass (Figure ). To summarize his findings so far, he presented with bradycardia due to complete AVB, paroxysmal atrial fibrillation and an unidentified cardiac mass. After implantation of a permanent pacemaker for complete AVB, anticoagulant therapy with rivaroxaban was started for paroxysmal atrial fibrillation. The patient was treated conservatively. Two months later, unexpectedly, follow-up evaluation by TTE and enhanced CT revealed an increase in size of the hollow interior cavity (Figure and E, Video 3). This suggested thrombolysis by rivaroxaban and offered useful additional information for the diagnosis. A non-coronary SVA filled with thrombus was the most likely preoperative diagnosis. Two weeks later, a non-coronary sinus plasty and thrombectomy were performed. Intraoperatively, a non-coronary SVA filled with chronic mural and fresh thrombus was found (Figure ). Electrocardiogram showed complete atrioventricular block with junctional escape rhythm. (A) Transthoracic echocardiography revealed a spherical mass (43 × 49 mm) at the centre of the heart (yellow arrows). (B) Enhanced computed tomography showed a well-defined, hollow, non-enhanced mass at the interatrial septum (yellow allows). (C) Transoesophageal echocardiography showed that the mass was close to the atrial septum without invasion. Two months after initiation of anticoagulant therapy, transthoracic echocardiography (D) and enhanced computed tomography (E) showed an increase in size of the hollow interior cavity. No uptake in the mass was found on 18F-fluorodeoxyglucose positron emission tomography/computed tomography. (A) Gross features of the specimen from the non-coronary sinus of Valsalva aneurysm. (B) Histological examination shows that the internal contents of the non-coronary sinus of Valsalva aneurysm consisted of thrombus.

Discussion

We present a rare case of a giant thrombosed SVA. Two aspects of this case are of particular interest. First, an SVA filled with thrombus can be challenging to diagnose because it mimics a cardiac tumour. The differential diagnosis of a spherical mass at the atrial septum would include primary or metastatic cardiac tumour. Echocardiography is the first-choice diagnostic procedure for assessing cardiac tumours. However, the utility of echocardiography for tissue characterization is limited. In our case, 18F-FDG PET/CT findings helped us make the diagnosis. In addition, serial echocardiography and enhanced CT examinations revealed a change in size of the hollow interior cavity, and in the thickness of the mass after anticoagulation therapy. These multimodality imaging features helped to differentiate it from the other possible interatrial masses mentioned above. Second, new-onset complete AVB as the first manifestation of an SVA is rare, although chest pain and dyspnoea due to rupture and aortic regurgitation are frequent initial symptoms. There are few reports of an SVA discovered by the onset of AVB. Anatomically, the atrioventricular (AV) node is close to the non- and right-coronary cusps. In this case, we presume that the non-coronary SVA grew large enough to compress the AV node. An SVA should be considered as a possible cause of AVB.

Conclusions

We describe a rare case of a giant thrombosed SVA masquerading as a cardiac tumour. 18F-FDG PET/CT and serial imaging studies were helpful in the differential diagnosis of cardiac tumour by providing additional information on the tissue composition.

Lead author biography

Wakana Sato is a graduate of the Akita University School of Medicine in 2006. Currently, she is an echocardiologist, and Assistant Professor in Department of Cardiovascular Medicine, Akita University Graduate School of Medicine, Japan.

Supplementary material

Supplementary material is available at European Heart Journal - Case Reports online. Slide sets: A fully edited slide set detailing this case and suitable for local presentation is available online as Supplementary data. Consent: The authors confirm that written consent for submission and publication of this case report including images and associated text has been obtained from the patient in line with COPE guidance. Conflict of interest: None declared. Funding: None declared. Click here for additional data file.
  3 in total

1.  Ruptured congenital aneurysm of the sinus of Valsalva with persistent left superior vena cava imaged by intraoperative transesophageal echocardiography.

Authors:  M S Flynn; R Castello; L W McBride; A J Labovitz
Journal:  Am Heart J       Date:  1993-04       Impact factor: 4.749

2.  Complete heart block with diastolic heart failure and pulmonary edema secondary to enlarging previously diagnosed thrombosed aneurysm of sinus of valsalva in a patient with history of autosomal dominant polycystic kidney disease.

Authors:  Sherif Ali Eltawansy; Martin Miguel Amor; Maria Joana Thomas; Jeffrey Daniels
Journal:  Case Rep Cardiol       Date:  2015-03-11

3.  Valsalva aneurysm filled with thrombi mimicking a cardiac tumor.

Authors:  Yasuharu Lee; Naoki Mori; Daisuke Nakamura; Takahiro Yoshimura; Masayuki Taniike; Nobuhiko Makino; Hiroyasu Kato; Yasuyuki Egami; Ryu Shutta; Jun Tanouchi; Yoshio Yamada; Masami Nishino
Journal:  Korean Circ J       Date:  2012-12-31       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.